Lyme disease vaccine: Completed 11,000-patient Phase III trial

SmithKline Beecham, Philadelphia, Penn.
Product: Lyme disease

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE